Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VBI Vaccines Inc VBIVQ

Healthcare Biotechnology
VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The... see more

Recent & Breaking News (GREY:VBIVQ)

VBI Vaccines to Present at the Ladenburg Thalmann Healthcare Conference

MarketWire Canada September 26, 2016

VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of Its Preventative Cytomegalovirus Vaccine Candidate

MarketWire Canada September 20, 2016

VBI Vaccines to Present at the Rodman & Renshaw Annual Global Investment Conference

MarketWire Canada September 7, 2016

VBI Vaccines to Present at the Vaccine Congress

MarketWire Canada September 1, 2016

VBI Vaccines to Present at the Immuno-Oncology Summit

MarketWire Canada August 29, 2016

VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review

MarketWire Canada August 22, 2016

VBI Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer

MarketWire Canada July 25, 2016

VBI Vaccines Inc. (Nasdaq: VBIV) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire July 19, 2016

VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus

MarketWire Canada July 19, 2016

VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate

MarketWire Canada June 23, 2016

VBI Vaccines Announces Closing of $13.6 Million Private Placement

MarketWire Canada June 21, 2016

Ultra Lithium Starts Phase 1 Exploration at the Georgia Lake Lithium Project in Northwestern Ontario, Canada

MarketWire Canada June 17, 2016

VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference

MarketWire Canada June 17, 2016

VBI Vaccines Announces Medulloblastoma Immunotherapy Program

MarketWire Canada June 16, 2016

VBI Vaccines to Host Hepatitis B Key Opinion Leader Meeting

MarketWire Canada June 10, 2016

VBI Vaccines to Present at the BIO International Convention

MarketWire Canada June 3, 2016

VBI Vaccines to Present at the Jefferies Healthcare Conference

MarketWire Canada May 27, 2016

Coventry Resources Inc.: Redomicile from Canada to Australia

MarketWire Canada May 27, 2016

Additional Details Relating to the SciVac Therapeutics and VBI Vaccines Merger Transaction

GlobeNewswire May 9, 2016

SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction

GlobeNewswire May 9, 2016